BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
BeyondSpring, Inc. NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on...